Crinetics Pharmaceuticals, Inc. Detailed Financials
Full historical quarterly statements
| Metric | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 10.7M | 6.2M | 143K | 1.0M | 361K | 0 | 0 | 399K |
| Cost of Goods Sold | 200K | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Gross Profit | 10.5M | 6.2M | 143K | 1.0M | 361K | 0 | 0 | 399K |
| R&D Expenses | 100.1M | 85.1M | 90.5M | 80.3M | 76.2M | 66.6M | 61.9M | 58.3M |
| Operating Expenses | 150.9M | 139.8M | 142.7M | 130.1M | 111.8M | 94.7M | 87.8M | 83.2M |
| Operating Income | -140.4M | -133.7M | -142.6M | -129.1M | -111.4M | -94.7M | -87.8M | -82.8M |
| Other Income / Gains | 12.5M | 11.0M | 12.5M | 13.5M | 14.6M | 14.2M | 11.0M | 8.7M |
| Net Income | -127.8M | -122.8M | -130.1M | -115.6M | -96.8M | -80.6M | -76.8M | -74.1M |
| EPS (Diluted) | -1.23 | -1.30 | -1.38 | -1.23 | -1.04 | -0.88 | -0.96 | -0.94 |
| Reported Currency | USD | USD | USD | USD | USD | USD | USD | USD |
| Gross Profit Ratio | 0.981 | 1.00 | 1.00 | 1.00 | 1.00 | 0 | 0 | 1.00 |
| General And Administrative Expenses | 0 | 53.7M | 52.3M | 49.8M | 35.5M | 28.2M | 25.9M | 24.8M |
| Selling And Marketing Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling General And Administrative Expenses | 50.8M | 53.7M | 52.3M | 49.8M | 35.5M | 28.2M | 25.9M | 24.8M |
| Other Expenses | 0 | 1.1M | 0 | 0 | 0 | 0 | 0 | 0 |
| Cost And Expenses | 151.1M | 139.8M | 142.7M | 130.1M | 111.8M | 94.7M | 87.8M | 83.2M |
| Interest Income | 12.7M | 11.2M | 12.5M | 13.5M | 14.8M | 14.4M | 11.0M | 8.7M |
| Interest Expense | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Depreciation And Amortization | 1.2M | 994K | 1.0M | 959K | 925K | 788K | 770K | 753K |
| Ebitda | -139.2M | -132.7M | -141.6M | -128.2M | -110.5M | -94.0M | -87.0M | -82.0M |
| Ebitdaratio | -12.97 | -21.534 | -990.028 | -124.30 | -306.039 | 0 | 0 | -205.589 |
| Operating Income Ratio | -13.078 | -21.696 | -997.105 | -125.23 | -308.601 | 0 | 0 | -207.476 |
| Income Before Tax | -127.8M | -122.6M | -130.1M | -115.6M | -96.8M | -80.6M | -76.8M | -74.1M |
| Income Before Tax Ratio | -11.91 | -19.905 | -909.727 | -112.16 | -268.072 | 0 | 0 | -185.602 |
| Income Tax Expense | 0 | 180K | 0 | 0 | 0 | 0 | 0 | 0 |
| Net Income Ratio | -11.91 | -19.934 | -909.727 | -112.16 | -268.072 | 0 | 0 | -185.602 |
| Epsdiluted | -1.23 | -1.30 | -1.38 | -1.23 | -1.04 | -0.88 | -0.96 | -0.94 |
| Weighted Average Shs Out | 104.1M | 94.1M | 94.2M | 93.8M | 93.1M | 91.5M | 80.1M | 79.0M |
| Weighted Average Shs Out Dil | 104.1M | 94.1M | 94.2M | 93.8M | 93.1M | 91.5M | 80.1M | 79.0M |